Literature DB >> 12592465

European Society of Urogenital Radiology guidelines on administering contrast media.

S K Morcos1, H S Thomsen.   

Abstract

The European Society of Urogenital Radiology is committed to improving knowledge and understanding about contrast media. There seemed to be little agreement about the best approach for the prevention of contrast medium-induced nephrotoxicity or generalized adverse reactions and the use of intravascular contrast media in diabetic patients receiving metformin. There was also concern that there might be discrepancies between current practice and published recommendations on these subjects. The Contrast Media Safety Committee of the European Society of Urogenital Radiology has produced practical guidelines on these important topics based on wide consensus and extensive review of the literature. The details of the guidelines are presented in this review.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12592465     DOI: 10.1007/s00261-001-0186-5

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  10 in total

Review 1.  [Multislice CT urography Aspects for technical management and clinical application].

Authors:  J Kemper; G Adam; C Nolte-Ernsting
Journal:  Radiologe       Date:  2005-10       Impact factor: 0.635

2.  Effects of hydration combined with Shenfu injection on contrast-induced acute kidney injury in acute coronary syndrome patients undergoing percutaneous coronary intervention.

Authors:  Zhen Guo; Dandan Niu; Yaren Yu; Di Zhen; Wenhua Li
Journal:  Biomed Rep       Date:  2017-09-22

3.  Vascular Imaging With Ferumoxytol as a Contrast Agent.

Authors:  Michael D Hope; Thomas A Hope; Chengcheng Zhu; Farshid Faraji; Henrik Haraldsson; Karen G Ordovas; David Saloner
Journal:  AJR Am J Roentgenol       Date:  2015-06-23       Impact factor: 3.959

4.  Alprostadil protects type 2 diabetes mellitus patients treated with metformin from contrast-induced nephropathy.

Authors:  Jing Wang; Xiaobo Ai; Li Li; Yanyan Gao; Nina Sun; Changgui Li; Weihong Sun
Journal:  Int Urol Nephrol       Date:  2017-06-27       Impact factor: 2.370

5.  Periprocedural hemoglobin drop and contrast-induced nephropathy in percutaneous coronary intervention patients.

Authors:  Kang Hyu Lee; Sang Rok Lee; Kyung Pyo Kang; Huy Jung Kim; Sun Hwa Lee; Kyoung-Suk Rhee; Jei Keon Chae; Won Ho Kim; Jae Ki Ko
Journal:  Korean Circ J       Date:  2010-02-23       Impact factor: 3.243

6.  New guidelines on the use of iodinated contrast media: a report on an implementation project.

Authors:  M G Bonetti; A Vesprini; M Concetti; S Ventrella; M F Spagna; S Mancinelli; M Santini; A Romanelli; P Pantanetti; C Cameli; L Bonanni; L Baffoni
Journal:  Radiol Med       Date:  2009-03-25       Impact factor: 3.469

7.  The management of type 2 diabetic patients with hypoglycaemic agents.

Authors:  Man-Wo Tsang
Journal:  ISRN Endocrinol       Date:  2012-05-07

8.  Evaluation of the protective effect of N-acetylcysteine on contrast media nephropathy.

Authors:  Aiyoub Pezeshgi; Negin Parsamanesh; Goodarz Farhood; Khalil Mahmoodi
Journal:  J Renal Inj Prev       Date:  2015-09-01

9.  Quercetin, a Promising Clinical Candidate for The Prevention of Contrast-Induced Nephropathy.

Authors:  Laura Vicente-Vicente; David González-Calle; Alfredo Ginés Casanova; María Teresa Hernández-Sánchez; Marta Prieto; Juan Carlos Rama-Merchán; Javier Martín-Moreiras; Francisco Martín-Herrero; Pedro Luis Sánchez; Francisco J López-Hernández; Ignacio Cruz-González; Ana Isabel Morales
Journal:  Int J Mol Sci       Date:  2019-10-08       Impact factor: 5.923

10.  Effect of renin-angiotensin-system blockers on contrast-medium-induced acute kidney injury after coronary angiography.

Authors:  Ja-Jun Goo; Jae-Joon Kim; Ji-Hoon Kang; Kyoung-Nyoun Kim; Ki-Sup Byun; Mi-kyung Kim; Tae-Ik Kim
Journal:  Korean J Intern Med       Date:  2014-02-27       Impact factor: 2.884

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.